PATENT CLAIM ANALYSIS

Application Number: 15971017
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "183000"]

Abstract:
This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Claim (Index 27):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein each R B  is independently unsubstituted phenyl, 4-fluoro-phenyl, 3-fluorophenyl, 2-fluorophenyl, CH 2 (phenyl), CH(CH 2 OH)phenyl, Br, Cl, CN, CH 3 , CHF 2 , CH 2 CH 3 , CH 2 OCH 3 , CH 2 OCH 2 CH 3 , CH(CH 3 ) 2 , CH(CH 2 OH)CH 2 CH 3 , CH(CH 2 OH)CH 3 , CH 2 CH 2 OH, CH 2 CH(OH)(CH 3 ), OCH 3 , OCH 2 CH 3 , C(O)NH 2 , C(O)CH 3 , 2,5-difluorophenyl, 3-pyridinyl, 2-pyridinyl, 1-methyl-1H-pyrazol-4-yl, 1-methyl-1H-pyrazol-3-yl, 1-methyl-1H-pyrazol-5-yl, 1,4-dimethyl-1H-pyrazol-3-yl, 1,5-dimethyl-1H-pyrazol-3-yl, 2-methylthiazol-5-yl, cyclohexyl, 3-cyanophenyl, 5-methylisoxazol-3-yl, 5-fluoropyridin-3-yl, 5-fluoropyridin-2-yl, 3-cyanophenyl, CH 2 CN, thiazol-4-yl, 6-methylpyridin-3-yl, 2-methylpyridin-3-yl, 6-methylpyridin-2-yl, pyrimidin-2-yl, morpholin-4-yl, cyclopropyl, oxazol-2-yl, CCCH(OH)(CH 3 ), or C(O)NH(4-fluoro-phenyl).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.13793
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15469975', '15234690', '15624850', '15247499', '15151259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8476928321743448
- 35 USC 102 Novelty (BERT): 0.6061427277787146
- Combined Prediction Score: 0.8235378217347817
- Mean Citation Score: 531.0717219999998
- Max Citation Score: 638.51373
- Similarity Product: 466.43362181165634

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test